HUTCHMED (China) Limited (AIM:HCM)
216.00
0.00 (0.00%)
Oct 16, 2026, 4:35 PM GMT
HUTCHMED (China) Employees
HUTCHMED (China) had 1,790 employees as of June 30, 2026. That makes HUTCHMED (China) the 10,954th largest employer in the world and 256th in the United Kingdom.
Employees
1,790
Change
n/a
Growth
n/a
Revenue / Employee
231.21K GBP
Profits / Employee
7.53K GBP
Market Cap
1.88B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 1,790 | - | - |
| Dec 31, 2025 | 1,796 | -15 | -0.83% |
| Dec 31, 2024 | 1,811 | -177 | -8.90% |
| Dec 31, 2023 | 1,988 | -37 | -1.83% |
| Dec 31, 2022 | 2,025 | 265 | 15.06% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Haleon | 24,535 |
| Hikma Pharmaceuticals | 9,500 |
| Allergy Therapeutics | 584 |
| ECO Animal Health Group | 213 |
| Shield Therapeutics | 61 |
| Chill Brands Group | 11 |
| Provexis | 2 |
HUTCHMED (China) News
- 8 days ago - HUTCHMED (China) Ltd (HCM) Stock Up 3.1% but GF Value Says Overvalued -- GF Score: 78/100 - GuruFocus
- 9 days ago - HUTCHMED (China) Ltd (HCM) Shares Fall 4.3% -- What GF Score of 77 Tells Investors - GuruFocus
- 17 days ago - HUTCHMED (China) Ltd (HCM) Shares Surge 3.4% -- What GF Score of 79 Tells Investors - GuruFocus
- 19 days ago - HUTCHMED Seeks FDA Approval For ORPATHYS-TAGRISSO In Resistant Lung Cancer - Nasdaq
- 19 days ago - AstraZeneca files US FDA application for HUTCHMED lung cancer drug combination - Reuters
- 19 days ago - Hutchmed says AstraZeneca submits NDA for ORPATHYS+TAGRISSO in NSCLC - TheFly
- 19 days ago - HUTCHMED Announces Submission of US NDA for ORPATHYS® plus TAGRISSO® in MET-Driven EGFR-Mutated Lung Cancer - GlobeNewsWire
- 20 days ago - Hutchmed (HCM) Launches Phase Ia Trial for HMPL-A830 in Advanced Solid Tumors - GuruFocus